COMPASS Pathways Plc - American (CMPS) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.34
- Estimate
- -$0.33
- Surprise
- -1.6%
- Score today
- 5.4/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
COMPASS Pathways Plc - American (CMPS) reported a wider loss than forecast — adjusted EPS of -$0.34 against the -$0.33 estimate (a 1.6% shortfall).
Coverage in the report window
- BTIG Reiterates Buy on Compass Pathways, Maintains $25 Price Target — benzinga, 2026-11-03
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session — benzinga, 2026-11-03
- Compass Pathways Q3 EPS $(0.31) Beats $(0.43) Estimate — benzinga, 2026-11-03
Where TrendMatrix's rating stands now
TrendMatrix currently rates CMPS Sell at 5.4/10; no pre/post engine snapshot brackets this report.
1 of the last 4 quarters beat the estimate; this quarter's -1.6% surprise compares with a -15.1% four-quarter average.
What argues against it
- Concentration risk — Pipeline: COMP360 psilocybin treatment (sole clinical program)
- Quality below floor (1.6 < 4.0)
- Momentum score 4.3/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $8.59
- Price target
- $21.38
- Stop
- $7.99
- Upside to target
- +148.9%
- Reward-to-risk
- 9.9:1
Risk check: trading volume is running 2.7× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-04 — shown for context, not personalized investment advice.
CMPS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $1.19B
- P/E (fwd)
- -6.0
- 52-week range
- $4.88–$15.87
- Off 52-week high
- 45.9%
- RSI (14)
- 34
- Volume vs avg
- 2.67×
- Score today
- 5.4/10